| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |